C12Q 2523/113
Denaturating agents
C12Q2523/113 (Denaturating agents) appears on 5 US grants and 10 published applications in this corpus.
Search patents in C12Q- Granted patents
- 5
- Published applications
- 10
- Assignees
- 7
- Inventors
- 23
- Latest grant
- 7 May 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2015 | 0 | 1 |
| 2016 | 0 | 0 |
| 2017 | 0 | 1 |
| 2018 | 0 | 3 |
| 2019 | 0 | 0 |
| 2020 | 4 | 1 |
| 2021 | 0 | 1 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 1 | 2 |
| 2025 | 0 | 1 |
By publication year.
Recent patents
- Methods for purification of messenger RNA7 May 2024US 11,976,272 B2Translate Bio, Inc.
- Methods for purification of messenger RNA20 Oct 2020US 10,808,241 B2Translate Bio, Inc.
- Method, lysis solution and kit for selectively depleting animal nucleic acids in a sample19 May 2020US 10,655,122 B2Qiagen GmbH
- Hybridization compositions and methods19 May 2020US 10,655,177 B2Agilent Technologies, Inc.
- Enhanced utilization of surface primers in clusters17 Mar 2020US 10,590,464 B2Illumina Cambridge Limited
- Methods and formulations for denaturing dna2 Jan 2025US 2025/0002973 A1Illumina, Inc.
- Using dried sodium hydroxide to denature double stranded dna4 Jul 2024US 2024/0218423 A1Illumina, Inc.
- Method for amplifying free nucleic acids directly from one drop of unpurified sample4 Jan 2024US 2024/0002903 A1
- Methods For Purification of Messenger RNA29 Apr 2021US 2021/0123041 A1Translate Bio, Inc.
- Method, lysis solution and kit for selectively depleting animal nucleic acids in a sample30 Jul 2020US 2020/0239871 A1Qiagen GmbH
Most cited
By later US patents